找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cell Penetrating Peptides; Methods and Protocol ülo Langel Book 2022Latest edition The Editor(s) (if applicable) and The Author(s), under e

[復(fù)制鏈接]
樓主: 小巷
51#
發(fā)表于 2025-3-30 08:16:13 | 只看該作者
52#
發(fā)表于 2025-3-30 15:05:31 | 只看該作者
53#
發(fā)表于 2025-3-30 20:24:54 | 只看該作者
In Silico Design of Chemically Modified Cell-Penetrating Peptidesng drug delivery vehicles. Numerous in silico tools have been developed over the years to design and predict the cell-penetrating peptides that contain natural amino acids. The majority of natural cell-penetrating peptides have several limitations including stability, immunogenicity as well as got e
54#
發(fā)表于 2025-3-30 21:46:32 | 只看該作者
55#
發(fā)表于 2025-3-31 04:51:26 | 只看該作者
A Native CPP from Rattlesnake with Therapeutic and Theranostic Propertiestides can rely on a high content of positive charges, as it is the case of the native CPP crotamine. Crotamine is a polypeptide of about 42 amino acid residues with high content of basic residues as Arg and Lys. Although most of known CPPs are linear peptides,?native crotamine from the venom of a So
56#
發(fā)表于 2025-3-31 08:54:56 | 只看該作者
57#
發(fā)表于 2025-3-31 09:42:27 | 只看該作者
Enhancing the Therapeutic Potential of Extracellular Vesicles Using Peptide Technology EVs are able to transfer their contents (including nucleic acids, proteins, lipids, and small molecules) to recipient cells, and thus hold great promise as drug delivery vehicles. However, their therapeutic application is limited by lack of efficient cargo loading strategies, a need to improve EV t
58#
發(fā)表于 2025-3-31 15:10:04 | 只看該作者
59#
發(fā)表于 2025-3-31 17:48:26 | 只看該作者
Membrane Molecular Interactions and Induced Structures of CPPsal properties, they are classified as three main groups, namely hydrophobic, amphipathic, and hydrophilic. They are capable of interacting with the cell membrane without inducing serious toxicity, and they can carry cargo molecules across the membrane. Cargo molecules could be different therapeutics
60#
發(fā)表于 2025-4-1 00:23:05 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-29 09:44
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
营口市| 廉江市| 唐河县| 南平市| 蓬溪县| 中西区| 若羌县| 镇宁| 嫩江县| 进贤县| 瑞安市| 克什克腾旗| 惠水县| 济源市| 公主岭市| 象山县| 巴中市| 治县。| 义马市| 房产| 兴业县| 兴隆县| 新巴尔虎右旗| 集安市| 商洛市| 江山市| 长葛市| 泸水县| 武清区| 岑巩县| 称多县| 黄冈市| 托克托县| 鄯善县| 泰顺县| 揭阳市| 湘西| 榆树市| 商城县| 惠东县| 大理市|